12-49037694-G-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_003482.4(KMT2D):c.9662C>A(p.Thr3221Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000119 in 1,586,374 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000696 AC: 106AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000161 AC: 33AN: 204738Hom.: 0 AF XY: 0.000118 AC XY: 13AN XY: 110254
GnomAD4 exome AF: 0.0000572 AC: 82AN: 1434030Hom.: 0 Cov.: 32 AF XY: 0.0000408 AC XY: 29AN XY: 710756
GnomAD4 genome AF: 0.000696 AC: 106AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000725 AC XY: 54AN XY: 74484
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
- -
Kabuki syndrome Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
KMT2D-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at